Sanctuary Advisors LLC Buys Shares of 17,018 ARK Genomic Revolution ETF (BATS:ARKG)

Sanctuary Advisors LLC bought a new stake in ARK Genomic Revolution ETF (BATS:ARKG) in the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 17,018 shares of the company’s stock, valued at approximately $401,000.

Other institutional investors also recently bought and sold shares of the company. Hemington Wealth Management grew its position in ARK Genomic Revolution ETF by 44.6% in the 4th quarter. Hemington Wealth Management now owns 1,310 shares of the company’s stock valued at $30,000 after acquiring an additional 404 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new position in ARK Genomic Revolution ETF in the 4th quarter valued at about $45,000. National Bank of Canada FI grew its position in ARK Genomic Revolution ETF by 28.4% in the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after acquiring an additional 920 shares in the last quarter. IHT Wealth Management LLC acquired a new position in ARK Genomic Revolution ETF in the 3rd quarter valued at about $203,000. Finally, Hilltop Holdings Inc. acquired a new position in ARK Genomic Revolution ETF in the 3rd quarter valued at about $237,000.

ARK Genomic Revolution ETF Price Performance

Shares of ARK Genomic Revolution ETF stock opened at $23.13 on Tuesday. The stock’s 50 day moving average is $25.96 and its 200-day moving average is $25.40.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.